Interleukin-10 down-regulates oxLDL induced expression of scavenger receptor A and Bak-1 in macrophages derived from THP-1 cells

Abstract

Here, we investigated the therapeutic potential of IL-10 by testing its effects on oxLDL-induced lipoprotein uptake and apoptosis by flow cytometry in THP-1-derived macrophages. The mRNA and protein expressions of lipid scavenger receptors (SR-A, CD36) and apoptosis-related proteins (Bcl-2, Bak-1) were also detected. Co-incubation of oxLDL with IL-10 reduced DiI-oxLDL uptake by 16.1 ± 3.8%, 35.2 ± 3.8% and 28.9 ± 1.8% at 6, 12 and 24 h of treatment, respectively. Furthermore, treatment with oxLDL for 24 h enhanced the SR-A mRNA and protein expressions by 89.3 ± 17.1% and 70.1 ± 17.6%, respectively. IL-10 abrogated the oxLDL-induced SR-A mRNA expression by 50.2 ± 3.9% and its protein by 45.6 ± 1.9%. Meanwhile IL-10 had no effect on the oxLDL-induced increase of CD36 expression. IL-10 inhibited the oxLDL-induced cell apoptosis in a time-dependent manner by 17.3 ± 3.3%, 36.4 ± 2.8% and 31.0 ± 4.3% at 6, 12 and 24 h, respectively. OxLDL increased Bak-1 mRNA and protein expressions by 38.4 ± 13.3% and 36.9 ± 12.1%, respectively. However co-stimulation of oxLDL with IL-10 for 24 h inhibited Bak-1 expression to 28.4 ± 7.2% (mRNA) and 25.7 ± 6.3% (protein). Meanwhile, IL-10 had no effect on the oxLDL-induced decrease of Bcl-2 expression. Our findings suggested that IL-10 reduced the oxLDL-induced lipoprotein uptake and apoptosis partly via down-regulating the oxLDL-induced expression of SR-A and Bak-1 in THP-1-derived macrophages.